Cathflo Activase

Active Ingredient(s): Alteplase, tPA
FDA Approved: * June 18, 1996
Pharm Company: * GENENTECH
Category: Blood Clotting (Hemostasis)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cathflo Activase Overview

1A5H, 1BDA, 1PK2, 1PML, 1RTF, 1TPG, 1TPK, 1TPM, 1TPN, 5BRRIdentifiersAliasesPLAT, T-PA, TPA, plasminogen activator, tissue typeExternal IDsOMIM: 173370 MGI: 97610 HomoloGene: 717 GeneCards: PLAT Gene location (Human)Chr.Chromosome 8 (human)[1]Band8p11.21Start42,174,718 bp[1]End42,207,709 bp[1]Gene location (Mouse)Chr.Chromosome 8 (mouse)[2]Band8 A2|8 11.42 cMStart22,757,727 bp[2]End22,782,844 bp[2...

Read more Cathflo Activase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tissue_plasminogen_activator

Recent Cathflo Activase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alteplase, tPA
  • Injection: 100mg, 2mg, 50mg
  • Vial: 100mg/vial, 2mg/vial, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cathflo Activase: (1 result)

Sorted by National Drug Code
  • 50242-041 Cathflo Activase 2.2 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Genentech, Inc.

Other drugs which contain Alteplase, tPA or a similar ingredient: (2 results)